All three tenses have at least two readings, so the archetype blend applies as printed.
Of the nine metrics, 7 read as filed from the record and 2 are SI estimates, each with its reasoning, its confidence and what would change it on its card.
What did they actually do?
Has it survived what it has been through?
2 warning events since 2021; the latest 2025-05-01.
From the record
Intercure Ltd.'s filings since 2021 show 2 warning events: a late-report notice (Form NT 10-K or NT 10-Q, 2 times, the latest 2025-05-01) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
+92.9% a year over 6 filed years; profitable in 2 of 6.
From the record
Intercure Ltd.'s 6 filed years say what it did: revenue went from ILS 9 million in fiscal 2019 to ILS 239 million in fiscal 2024, up 92.9% a year; it rose in 3 of 5 years; the deepest fall was 39% from fiscal 2022 to fiscal 2024; net income was positive in 2 of 6 of those years (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
SI estimate 7.3/10, confidence 35 of 100 (one part).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Intercure Ltd.'s shareholder treatment is put at 7.3 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the top 27% of 464 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.
What are they doing right now?
Is it financially healthy right now?
ROE -18%: lost 18¢ per shareholder dollar. Leverage 48%: owes 48¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2024-12-31, Intercure Ltd. lost about 18 cents for every dollar of shareholders' money, and gross profitability: its products earned about 4 cents per dollar of everything the company owns. Leverage: it owed about 48 cents per dollar of assets, and net share issuance: its share count grew 0.7% over the year (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
top 47% of 315 in its family; net margin -30.5%.
From the record
Intercure Ltd.'s standing among 315 graded names in its industry family: revenue of ILS 239 million in fiscal 2024 is not ranked by size, since the family reports in another currency; a net margin of -30.5% ranks in the top 36%; revenue growth of 2.8% a year over the last 3 filed years ranks in the bottom 42% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
SI estimate 5.0/10, confidence 20 of 100 (family median).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Intercure Ltd.'s leadership is put at 5.0 of 10 with a confidence of 20 of 100, because it files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-04-16 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 7 months and cannot see past it; a floor under five years is not read as years in charge, so the desk assumes the typical reading of its industry family, the median of 371 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.
What are they set up to do next?
How much room does it have to grow?
bottom 19% of 273 in its family for room to expand.
From the record
Intercure Ltd.'s room to grow, from the newest filed statements (fiscal 2024): cash of ILS 78 million against debt of ILS 183 million leaves -13.7% of its assets as net cash, bottom 9% of its family; cash from operations less capital spending is -29.9% of revenue (top 41%); a gross margin of 12.7% (bottom 7%); research spending of 0.2% of revenue (bottom 1%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
bottom 19% of 306 in its family for growth drivers.
From the record
Intercure Ltd.'s growth drivers, from the filed years to fiscal 2024: revenue grew 2.8% a year over the last three filed years against 92.9% over all 6, slowing (bottom 5% of its family); the newest year grew -32.8% (bottom 23%); research spending grew -30.5% a year (bottom 12%); capital spending grew -32.2% a year (bottom 36%) (its annual reports). Intercure Ltd. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
bottom 16% of 233 in its family for expectations against reality.
From the record
Intercure Ltd.'s newest year against its own record: revenue of ILS 239 million in fiscal 2024 came in 47.2% below the ILS 452 million its prior three years' pace pointed to (bottom 20% of its family); net income of ILS 73 million against a prior three-year average of ILS 4 million (bottom 3%); a net margin of -30.5% against -1.1% before (bottom 24%) (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made